News
Billy Idol reveals he nearly died of a heroin overdose in London in 1984 in the new documentary 'Billy Idol Should Be Dead,' ...
Recursion is eliminating approximately 20% of its workforce, in a restructuring that reflects challenges seen across the biopharma industry.
From naloxone to drug-checking, harm reduction grows at music festivals—though stigma and laws still pose limits.
Mark Cuban’s Cost Plus Drugs Co. has expanded operations across its drug manufacturing, distribution and partnership enterprises. The company continues to grow its presence in the generic drug market ...
Despite how expensive genAI is right now, there’s an assumption pricing will soar in a year or two — as soon as enterprises ...
Insmed achieved positive phase 2b results for TPIP in PAH. Click here to find out why INSM stock is a Strong Buy.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
WASHINGTON — Trump administration officials are expected to release more details on their plan to lower prescription drug ...
Republican presidential candidate Donald Trump has proposed a “Most Favored Nation” pricing plan to lower the cost of ...
Ron Lanton, Partner, Lanton Law, weighs in on the potential international trade, pricing, and access implications of tying US drug costs to those in other developed countries under the Most Favored ...
Lansing's two hospitals and systems are charging very different prices for the same medications, a Michigan Health Purchasers ...
President Donald Trump’s proposal to peg American drug costs to prices paid in other countries risks upending Medicaid’s drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results